GeneCentric Therapeutics has secured $8m in new funding to accelerate the development of its RNA-based liquid biopsy platform ...

NURTuRE-AKI is a novel observational study that collects longitudinal data and biological samples from fully consented acute kidney injury ("AKI") patients, developed as part of a research consortium ...

From microscopes to monitors, pathology is undergoing a digital revolution. Learn how this transformation is reshaping ...

(UroToday.com) The Interdisciplinary Genitourinary Cancer Forum 2025, held in St. Petersburg, Florida, United States, was host to the Prostate Cancer Session 2: Local Treatments. Dr. Peter Carroll ...

My mother has been diagnosed with breast cancer, and I’m helping with her medical appointments. Her oncologist says she needs a liquid biopsy. She has already had a ...

The global Breast Biopsy Devices Market is projected to be valued at USD 2.47 billion in 2025 and is expected to reach USD 4.21 billion by 2035, registering a CAGR of 5.5% during the forecast period.

The global breast biopsy market is anticipated to grow at a steady CAGR of 5.5% during the forecast period 2020-2026, according to a report by Gen Consulting Company.

A new PET/CT imaging technique that visualizes activated fibroblasts in the heart muscle enables early detection of multiple forms of cardiomyopathy, according to research presented at the Society of ...

AI model crossNN identifies over 170 tumor types with high accuracy using genetic material, offering fast, non-invasive ...

GeneCentric Therapeutics has earned an initial $8m in a Series C funding round, marking a step towards the launch and ...

A biopsy of metastatic sites costs around $16,000, and while Angle hasn’t divulged its pricing plans for Parsortix' clinical applications for research purposes the single-use test costs around $100.

Some of the most harmful genetic changes in cancer are also the hardest to see. These structural alterations, deep within a tumor's DNA, can fuel aggressive growth and evade ...